Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Riovant Sciences

- PMLiVE

AZ and MSD launch ‘Never Miss’ for prostate cancer awareness

Prostate cancer is often symptomless and is the second most common cancer in men globally

- PMLiVE

Takeda’s Exkivity receives NICE recommendation for rare form of lung cancer

Patients with EGFR Exon20ins+ NSCLC make up approximately 2% of NSCLC cases

Women's health infographic

Changing the narrative: women reveal what they want from health communication and health brands

In this white paper, we interview more than 1,000 women to gain deep insights into healthcare, what they really think about the gender health gap and how health brands and...

Thrive Agency

- PMLiVE

NHS reports rise in prostate cancer treatments in England

Prostate Cancer UK’s risk checker has been used over a million times since its launch in February

- PMLiVE

Takeda’s dengue vaccine candidate recommended for approval by CHMP

Dengue disease causes around 390 million infections and 500,000 hospitalisations each year

- PMLiVE

Novartis bags CHMP recommendation for prostate cancer drug Pluvicto

The recommendation is for use in combination with androgen deprivation therapy

- PMLiVE

Empowering the GP to help women feel the vagisil prohydrate difference

Vagisil were launching their first product available on prescription. It was a tough task to put Vagisil ProHydrate front of mind and turn GPs into advocates. That’s why they came...

Create Health

- PMLiVE

Medscape Education Announces Virtual Conference Focused on Elevating Women’s Healthcare

Medscape Education announces a new virtual conference focused on equipping clinicians with the latest advances in women's health.

Medscape Education Global

- PMLiVE

Pfizer’s Talzenna combination treatment meets primary endpoint in phase 3 prostate cancer study

An improvement in radiographic progression-free survival was demonstrated

Women's health brand opportunities infographic

Women turn to brands for health advice after feeling sidelined by professionals

Women want brands to provide more health information, representing huge opportunities for brands to advocate for their consumers.

Thrive Agency

- PMLiVE

NICE rejects AstraZeneca and MSD’s Lynparza as NHS prostate cancer treatment

The drug will not be available as a treatment option for men with prostate cancer in England and Wales

- PMLiVE

New study shows pioneering test for endometrial cancer could significantly reduce diagnosis time

The study findings have been published in the Journal of Clinical Oncology

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links